Skin Cancer Research Today is a free monthly online journal that collates and summarizes the latest research about Skin Cancer, including details on identification, causes, prevention, treatment.

Volume 7 (2010), Issue 7 (July)

1. Chemokine/chemokine receptor interactions in extramedullary leukaemia of the skin in childhood AML: differential roles for CCR2, CCR5, CXCR4 and CXCR7.
   Pediatr Blood Cancer, 55(2): 344-8. [Abstract] [Full-text]
2. Neurocutaneous melanosis: surgical pathological features of an apparently hamartomatous lesion in the amygdala.
   J Neurosurg Pediatr, 6(1): 82-6. [Abstract] [Full-text]
3. Targeting KIT in melanoma: a paradigm of molecular medicine and targeted therapeutics.
   Biochem Pharmacol, 80(5): 568-74. [Abstract] [Full-text]
4. Targeting the MAPK pathway in melanoma: why some approaches succeed and other fail.
   Biochem Pharmacol, 80(5): 624-37. [Abstract] [Full-text]
5. BRAF as therapeutic target in melanoma.
   Biochem Pharmacol, 80(5): 561-7. [Abstract] [Full-text]
6. IRF4 variants have age-specific effects on nevus count and predispose to melanoma.
   Am J Hum Genet, 87(1): 6-16. [Abstract] [Full-text]
7. TLR4-mediated skin carcinogenesis is dependent on immune and radioresistant cells.
   EMBO J, 29(13): 2242-52. [Abstract] [Full-text]
8. Evidence of multiple infectious agents in mycosis fungoides lesions.
   Exp Mol Pathol, 89(1): 46-50. [Abstract] [Full-text]
9. Persistent ex vivo low number and functional in vitro recovery of circulating gammadelta T cells after removal of a cutaneous primary melanoma.
   Scand J Immunol, 72(2): 142-9. [Abstract] [Full-text]
10. A study of paclitaxel, carboplatin, and bortezomib in the treatment of metastatic malignant melanoma: a phase 2 consortium study.
    Cancer, 116(14): 3463-8. [Abstract] [Full-text]
11. Stromal expression of actin is a marker of aggressiveness in basal cell carcinoma.
    Hum Pathol, 41(8): 1128-37. [Abstract] [Full-text]
12. Biomarkers: the useful and the not so useful--an assessment of molecular prognostic markers for cutaneous melanoma.
    J Invest Dermatol, 130(8): 1971-87. [Abstract] [Full-text]
13. Curcumin selectively induces apoptosis in cutaneous T-cell lymphoma cell lines and patients' PBMCs: potential role for STAT-3 and NF-kappaB signaling.
    J Invest Dermatol, 130(8): 2110-9. [Abstract] [Full-text]
14. The impact of in vivo reflectance confocal microscopy on the diagnostic accuracy of lentigo maligna and equivocal pigmented and nonpigmented macules of the face.
    J Invest Dermatol, 130(8): 2080-91. [Abstract] [Full-text]
15. MicroRNA expression profiles associated with mutational status and survival in malignant melanoma.
    J Invest Dermatol, 130(8): 2062-70. [Abstract] [Full-text]
16. Functional modulation of IGF-binding protein-3 expression in melanoma.
    J Invest Dermatol, 130(8): 2071-9. [Abstract] [Full-text]
17. Enhanced death ligand-induced apoptosis in cutaneous SCC cells by treatment with diclofenac/hyaluronic acid correlates with downregulation of c-FLIP.
    J Invest Dermatol, 130(8): 2098-109. [Abstract] [Full-text]
18. Cutaneous CD4+ CD56+ hematologic malignancies.
    J Am Acad Dermatol, 63(2): 292-308. [Abstract] [Full-text]
19. Efficacy of propranolol in hepatic infantile hemangiomas with diffuse neonatal hemangiomatosis.
    J Pediatr, 157(2): 340-2. [Abstract] [Full-text]
20. Cutaneous extranodal NK/T-cell lymphoma: a clinicopathologic study of 5 patients with array-based comparative genomic hybridization.
    Blood, 116(2): 165-70. [Abstract] [Full-text]
21. Ratio of marked and excised sentinel lymph nodes and scintigraphic appearance time in melanoma patients with negative sentinel lymph node.
    Eur J Surg Oncol, 36(8): 783-8. [Abstract] [Full-text]
22. AMP-activated kinase (AMPK)-generated signals in malignant melanoma cell growth and survival.
    Biochem Biophys Res Commun, 398(1): 135-9. [Abstract] [Full-text]
23. Targeting glutamine metabolism sensitizes melanoma cells to TRAIL-induced death.
    Biochem Biophys Res Commun, 398(1): 146-52. [Abstract] [Full-text]
24. CLOVES syndrome with thoracic and central phlebectasia: increased risk of pulmonary embolism.
    J Thorac Cardiovasc Surg, 140(2): 459-63. [Abstract] [Full-text]
25. Prognostic information from sentinel lymph node biopsy in patients with thick melanoma.
    Arch Surg, 145(7): 622-7. [Abstract] [Full-text]
26. Extended experience and modifications in the design and concepts of the keystone design island flap.
    J Plast Reconstr Aesthet Surg, 63(8): 1359-63. [Abstract] [Full-text]
27. Gene signature of the metastatic potential of cutaneous melanoma: too much for too little?
    Clin Exp Metastasis, 27(6): 371-87. [Abstract] [Full-text]
28. The invasive growth potential of residual melanoma and melanoma in situ.
    Dermatol Surg, 36(8): 1251-7. [Abstract] [Full-text]
29. Electroporation therapy of skin cancer in the head and neck area.
    Dermatol Surg, 36(8): 1245-50. [Abstract] [Full-text]
30. A direct comparison of visual inspection, curettage, and epiluminescence microscopy in determining tumor extent before the initial margins are determined for Mohs micrographic surgery.
    Dermatol Surg, 36(8): 1240-4. [Abstract] [Full-text]
31. Nonmelanoma skin cancer of the ear: frequency, patients' knowledge, and photoprotection practices.
    Dermatol Surg, 36(8): 1232-9. [Abstract] [Full-text]

© 2004-2012 Skin Cancer Research Today. All Rights Reserved.